Rivas F - Search Results

1

Identification of Biologically Active Ganoderma lucidum Compounds and Synthesis of Improved Derivatives That Confer Anti-cancer Activities in vitro.

Martínez-Montemayor MM, Ling T, Suárez-Arroyo IJ, Ortiz-Soto G, Santiago-Negrón CL, Lacourt-Ventura MY, Valentín-Acevedo A, Lang WH, Rivas F. Martínez-Montemayor MM, et al. Among authors: rivas f. Front Pharmacol. 2019 Feb 19;10:115. doi: 10.3389/fphar.2019.00115. eCollection 2019. Front Pharmacol. 2019. PMID: 30837881 Free PMC article.

2

Synthesis and structure-activity relationship of disubstituted benzamides as a novel class of antimalarial agents.

Mitachi K, Salinas YG, Connelly M, Jensen N, Ling T, Rivas F. Mitachi K, et al. Among authors: rivas f. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4536-9. doi: 10.1016/j.bmcl.2012.05.124. Epub 2012 Jun 7. Bioorg Med Chem Lett. 2012. PMID: 22727641

3

Evaluation of Jatropha isabelli natural products and their synthetic analogs as potential antimalarial therapeutic agents.

Hadi V, Hotard M, Ling T, Salinas YG, Palacios G, Connelly M, Rivas F. Hadi V, et al. Among authors: rivas f. Eur J Med Chem. 2013 Jul;65:376-80. doi: 10.1016/j.ejmech.2013.04.030. Epub 2013 Apr 23. Eur J Med Chem. 2013. PMID: 23747806

4

Scalable and divergent total synthesis of (+)-colletoic acid, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor.

Ling T, Griffith E, Mitachi K, Rivas F. Ling T, et al. Among authors: rivas f. Org Lett. 2013 Nov 15;15(22):5790-3. doi: 10.1021/ol402842u. Epub 2013 Nov 1. Org Lett. 2013. PMID: 24175735

5

(+)-Dehydroabietylamine derivatives target triple-negative breast cancer.

Ling T, Tran M, González MA, Gautam LN, Connelly M, Wood RK, Fatima I, Miranda-Carboni G, Rivas F. Ling T, et al. Among authors: rivas f. Eur J Med Chem. 2015 Sep 18;102:9-13. doi: 10.1016/j.ejmech.2015.07.034. Epub 2015 Jul 23. Eur J Med Chem. 2015. PMID: 26241873

6

Synthesis and evaluation of colletoic acid core derivatives.

Ling T, Gautam LN, Griffith E, Das S, Lang W, Shadrick WR, Shelat A, Lee R, Rivas F. Ling T, et al. Among authors: rivas f. Eur J Med Chem. 2016 Mar 3;110:126-32. doi: 10.1016/j.ejmech.2016.01.027. Epub 2016 Jan 20. Eur J Med Chem. 2016. PMID: 26820555

7

Anti-proliferative evaluation of monoterpene derivatives against leukemia.

Gautam LN, Ling T, Lang W, Rivas F. Gautam LN, et al. Among authors: rivas f. Eur J Med Chem. 2016 May 4;113:75-80. doi: 10.1016/j.ejmech.2016.02.034. Epub 2016 Feb 16. Eur J Med Chem. 2016. PMID: 26922230

8

Novel vitexin-inspired scaffold against leukemia.

Ling T, Lang W, Feng X, Das S, Maier J, Jeffries C, Shelat A, Rivas F. Ling T, et al. Among authors: rivas f. Eur J Med Chem. 2018 Feb 25;146:501-510. doi: 10.1016/j.ejmech.2018.01.004. Epub 2018 Jan 31. Eur J Med Chem. 2018. PMID: 29407975

9

Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agents.

Ling T, Maier J, Das S, Budhraja A, Bassett R, Potts MB, Shelat A, Rankovic Z, Opferman JT, Rivas F. Ling T, et al. Among authors: rivas f. Eur J Med Chem. 2019 Feb 15;164:391-398. doi: 10.1016/j.ejmech.2018.12.059. Epub 2018 Dec 24. Eur J Med Chem. 2019. PMID: 30611980 Free article.

10

Development of ergosterol peroxide probes for cellular localisation studies.

Ling T, Lang WH, Martinez-Montemayor MM, Rivas F. Ling T, et al. Among authors: rivas f. Org Biomol Chem. 2019 May 29;17(21):5223-5229. doi: 10.1039/c9ob00145j. Org Biomol Chem. 2019. PMID: 31025693 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page